temozolomide has been researched along with Cerebral Hemorrhage in 4 studies
Cerebral Hemorrhage: Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA.
Excerpt | Relevance | Reference |
---|---|---|
" We present the case of a 26-year-old male suffering a fatal ICH in the context of treatment of a high grade glioma with temozolomide." | 7.76 | Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide. ( Anderson, WS; Dunn, I; Norden, A; Sure, D, 2010) |
" We present the case of a 26-year-old male suffering a fatal ICH in the context of treatment of a high grade glioma with temozolomide." | 3.76 | Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide. ( Anderson, WS; Dunn, I; Norden, A; Sure, D, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mendola, M | 1 |
Passeri, E | 1 |
Ambrosi, B | 1 |
Corbetta, S | 1 |
Sure, D | 1 |
Dunn, I | 1 |
Norden, A | 1 |
Anderson, WS | 1 |
Steckley, JL | 1 |
Watling, CJ | 1 |
Ng, W | 1 |
Benveniste, RJ | 1 |
Manzano, G | 1 |
Petito, CK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Secondary Prophylaxis Use of Romiplostim for the Prevention of Thrombocytopenia Induced by Temozolomide in Newly Diagnosed Glioblastoma Patients[NCT02227576] | Phase 2 | 20 participants (Actual) | Interventional | 2014-07-10 | Terminated (stopped due to Study halted for efficacy following the results of the interim analysis provided for in the protocol on 20 patients.) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for temozolomide and Cerebral Hemorrhage
Article | Year |
---|---|
Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cereb | 2014 |
Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Dacarbazine; Dose-Re | 2010 |
Glioblastoma in a patient with a hereditary cancer syndrome.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cerebral Hemorrhage; Colorectal Neoplasms; | 2008 |
Multifocal glioblastoma multiforme with synchronous spontaneous hemorrhage: case report.
Topics: Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cerebral Hemorr | 2008 |